Table 2 The sFLC concentrations and abnormal ratios of the investigated 186 patients
Variable | Baseline | After relapse | ||||
|---|---|---|---|---|---|---|
IgD subtype (n = 13) | Non-IgD subtypes (n = 173)a | P value | IgD subtype (n = 13) | Non-IgD subtypes (n = 96) | P value | |
sFLC [mg/L; median (range)] | ||||||
 κ | 12.10 (8.54–186.40) | 25.80 (1.49–17,780.00) | 0.567 | 15.60 (8.50–1708.00) | 56.00 (7.49–4541.00) | 0.655 |
 λ | 129.70 (8.46–4303.00) | 28.80 (1.33–17,600.00) | 0.151 | 583.86 (10.51–1092.00) | 687.00 (1.33–4000.00) | 0.412 |
κ/λ < 0.01 or > 100 [cases (%)] | 4 (30.78) | 13 (7.51) | 0.021 | 6 (46.15) | 7 (7.29) | < 0.001 |